Biopsy News and Research

RSS

Biopsy is the removal of cells or tissues for examination by a pathologist. The pathologist may study the tissue under a microscope or perform other tests on the cells or tissue. There are many different types of biopsy procedures. The most common types include: (1) incisional biopsy, in which only a sample of tissue is removed; (2) excisional biopsy, in which an entire lump or suspicious area is removed; and (3) needle biopsy, in which a sample of tissue or fluid is removed with a needle. When a wide needle is used, the procedure is called a core biopsy. When a thin needle is used, the procedure is called a fine-needle aspiration biopsy.

Researchers turn to new biomarkers for predicting organ transplant rejection

Organ transplants save lives, but the story doesn't end when a patient emerges from the operating room. Rejection episodes, in which the immune system rallies against the new organ, can occur.

31 Jan 2018

Expert panel releases updated guidelines for lung cancer molecular testing

Lung cancer treatment often pairs targeted therapies with genetic alterations driving the disease. This makes detecting these genetic alterations an essential step in diagnosis.

30 Jan 2018

New AASLD guideline focuses on improving diagnosis, treatment of liver cancer and NAFLD

A new Practice Guideline and Practice Guidance in Hepatology will help improve the diagnosis and treatment of patients with liver cancer as well as patients with non-alcoholic fatty liver disease (NAFLD), which can lead to liver cancer and is characterized by the build-up of extra fat in liver cells often due to obesity and diabetes.

27 Jan 2018

CureMatch’s co-founder is co-author of new article in Cancer Discovery journal

Igor F. Tsigelny, Ph.D., Co-founder and Chief Strategic Officer at CureMatch and research professor at University of California, San Diego, is a co-author of “Genomic landscape of cell-free DNA in patients with colorectal cancer” in Cancer Discovery along with group of colleagues from Duke University Medical Center, University of Texas MD Anderson Cancer Center, Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, Caris Life Sciences, and Guardant Health, Inc. organized by the Drs. Ryan B. Corcoran and Scott Kopetz.

27 Jan 2018

IPF Catalyst Challenge recognizes Owlstone Medical’s Breath Biopsy platform

Owlstone Medical Ltd, a diagnostics company developing a breathalyzer for disease, today announced it is one of the three winners of the global Idiopathic Pulmonary Fibrosis (IPF) Catalyst Challenge, sharing the $1,000.000 (£720,000 GBP) award, each receiving $333,333 (£240,000 GBP).

27 Jan 2018

Leading medical societies update molecular testing guideline for lung cancer

Rapid advancements in the molecular diagnostic testing of lung cancer have led to new treatments and greater hope for patients battling lung cancer, the most common cause of cancer death worldwide.

24 Jan 2018

Analysis finds overlooked crucial factor in determining prognosis for DIPGs

The prognosis for all children diagnosed with an aggressive brain tumor known as diffuse intrinsic pontine glioma and similar tumors has been mostly the same: dismal.

18 Jan 2018

When you need a breast screening, should you get a 3-D mammogram?

When I went to the imaging center for my regular mammogram last year, the woman behind the desk asked me if I'd like to get a "3-D" mammogram instead of the standard test I'd had in the past.

16 Jan 2018

Novel polygenic hazard score captures age variations of aggressive prostate cancer

An international team, led by researchers at the University of California San Diego School of Medicine, has developed and validated a genetic tool for predicting age of onset of aggressive prostate cancer, a disease that kills more than 26,000 American men annually.

12 Jan 2018

Research provides insights into mechanisms governing healthy longevity

Keio University Global Research Institute, Tokyo publishes the January 2018 issue of KGRI Research Frontiers that includes researcher video profiles of Keio University researchers and research highlights from high impact publications including 'Regenerative medicine needs collaboration in and out of science in order to face current and future challenges; ‘Does eating fish protect you from depression?’; ‘Insights into the molecular mechanisms leading to kidney dysfunction in diabetic patients’; and ‘Ageing to 100 and beyond: Insights from demographic, phenotypic and genetic studies.

12 Jan 2018

Computer model based on AI improves analysis of kidney biopsies

The ability to quantify the extent of kidney damage and predict the life remaining in the kidney, using an image obtained at the time when a patient visits the hospital for a kidney biopsy, now is possible using a computer model based on artificial intelligence.

11 Jan 2018

New blood stabilization method prolongs lifespan of blood samples for CTC profiling

A new blood stabilization method, developed at the Massachusetts General Hospital Center for Engineering in Medicine, significantly prolongs the lifespan of blood samples for microfluidic sorting and transcriptome profiling of rare circulating tumor cells (CTCs), living cancer cells carried in the bloodstream.

9 Jan 2018

FDA issues approval letter for Planmed Clarity 2D digital mammography system

The United States Food and Drug Administrationissued an approval letter for the Planmed Clarity 2D full-field digital mammography system on December 28th, 2017.

8 Jan 2018

New article demonstrates potential, feasibility of PlaqueTec Liquid Biopsy System to detect biomarkers for CAD

PLAQUETEC LTD today announced the publication of the first peer‐reviewed article demonstrating the feasibility and potential of the PlaqueTec Liquid Biopsy System™ to detect biomarkers for coronary artery disease (CAD).

5 Jan 2018

New MRI technology can reduce need for tumor biopsies

The most common type of tumor found in the kidney is generally quite small (less than 1.5 in). These tumors are usually found by accident when CAT scans are performed for other reasons and the serendipitous finding poses a problem for doctors.

3 Jan 2018

New classification criteria offers faster, more accurate path to diagnosing myositis diseases

The ability to diagnose myositis diseases and treat them properly just improved immensely. For more than 40 years, the criteria physicians have used to diagnose most myositis diseases has been based on expert opinion, not hard science.

21 Dec 2017

Post-workout muscle-building response better in people eating whole eggs than egg whites

People who consume 18 grams of protein from whole eggs or from egg whites after engaging in resistance exercise differ dramatically in how their muscles build protein, a process called protein synthesis, during the post-workout period, researchers report in a new study.

20 Dec 2017

Doing more harm than good? Epidemic of screening burdens nation’s older patients

Elena Altemus is 89 and has dementia. She often forgets her children's names, and sometimes can't recall whether she lives in Maryland or Italy.

20 Dec 2017

Prostate cancer researchers find significant disparities between two liquid biopsy providers

Two Johns Hopkins prostate cancer researchers found significant disparities when they submitted identical patient samples to two different commercial liquid biopsy providers.

15 Dec 2017

Study: Living Lyme disease bacteria found months after antibiotic treatment

Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the US, today announced results of two papers published in the peer-reviewed journals PLOS ONE and American Journal of Pathology, that seem to support claims of lingering symptoms reported by many patients who have already received antibiotic treatment for the disease.

14 Dec 2017

Biopsy News and Research

Further Reading

Researchers turn to new biomarkers for predicting organ transplant rejection

Expert panel releases updated guidelines for lung cancer molecular testing

New AASLD guideline focuses on improving diagnosis, treatment of liver cancer and NAFLD

CureMatch’s co-founder is co-author of new article in Cancer Discovery journal

IPF Catalyst Challenge recognizes Owlstone Medical’s Breath Biopsy platform

Leading medical societies update molecular testing guideline for lung cancer

Analysis finds overlooked crucial factor in determining prognosis for DIPGs

When you need a breast screening, should you get a 3-D mammogram?

Novel polygenic hazard score captures age variations of aggressive prostate cancer

Research provides insights into mechanisms governing healthy longevity

Computer model based on AI improves analysis of kidney biopsies

New blood stabilization method prolongs lifespan of blood samples for CTC profiling

FDA issues approval letter for Planmed Clarity 2D digital mammography system

New article demonstrates potential, feasibility of PlaqueTec Liquid Biopsy System to detect biomarkers for CAD

New MRI technology can reduce need for tumor biopsies

New classification criteria offers faster, more accurate path to diagnosing myositis diseases

Post-workout muscle-building response better in people eating whole eggs than egg whites

Doing more harm than good? Epidemic of screening burdens nation’s older patients

Prostate cancer researchers find significant disparities between two liquid biopsy providers

Study: Living Lyme disease bacteria found months after antibiotic treatment

Industry Focus eBook - Life Science Microscopy (3rd Edition) eBook

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Latest News